[Efficacy and Safety of Venetoclax-Based Induction Therapy in Acute Myeloid Leukemia].

Zhongguo shi yan xue ye xue za zhi(2023)

Cited 0|Views10
No score
Abstract
The VEN-based strategy has good treatment response and tolerance in newly diagnosed patients unfit for intensive therapy and R/R AML. The most common AEs are hematological toxicities and infection.
More
Translated text
Key words
acute myeloid leukemia,acute myeloid,induction therapy,venetoclax-based
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined